{
  "company": {
    "name": "Tubulis",
    "website": "https://tubulis.com/",
    "record": "https://startuphistory.org/c/tubulis.com"
  },
  "status": {
    "kind": "acquired",
    "label": "Acquired",
    "summary": "Its homepage says “Tubulis is now part of Gilead Sciences”.",
    "seen": {
      "on": "2026-11-06T21:29:02.815Z"
    }
  },
  "history_since": "2026-11-06T21:29:02.815Z",
  "baseline": {
    "snapshot_id": "6bac73e7641612f2a8e5584694d27273d40ad0114f84c558015cbde51e9c7620",
    "observed_at": "2026-11-06T21:29:02.815Z",
    "headline": "Tubulis is now part of Gilead Sciences",
    "description": "Tubulis is now part of Gilead Sciences www.gilead.com NEWS April 21 Tubulis to Present Phase I/IIa Trial Data for ADC Candidate TUB-040 in Platinum-resistant Ovarian Cancer in Rapid Oral Presentation ",
    "evidence": "https://tubulis.com/",
    "evidence_kind": "live_capture",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T21:29:02.815Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-06T21:29:02.815Z",
      "variants": [
        {
          "headline": "Tubulis is now part of Gilead Sciences",
          "subhead": "Tubulis is now part of Gilead Sciences www.gilead.com NEWS April 21 Tubulis to Present Phase I/IIa Trial Data for ADC Candidate TUB-040 in Platinum-resistant Ovarian Cancer in Rapid Oral Presentation ",
          "observed_at": "2026-11-06T21:29:02.815Z",
          "evidence": "https://tubulis.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Tubulis is now part of Gilead Sciences",
      "subhead": "Tubulis is now part of Gilead Sciences www.gilead.com NEWS April 21 Tubulis to Present Phase I/IIa Trial Data for ADC Candidate TUB-040 in Platinum-resistant Ovarian Cancer in Rapid Oral Presentation ",
      "from": "2026-11-06T21:29:02.815Z",
      "to": "2026-11-06T21:29:02.815Z",
      "captures": 1,
      "evidence": "https://tubulis.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "on": "2026-11-06T21:29:02.815Z"
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-6bac73e7641612f2a8e5584694d27273d40ad0114f84c558015cbde51e9c7620:6bac73e7641612f2a8e5584694d27273d40ad0114f84c558015cbde51e9c7620:acquired:20395c538a96179f",
      "before_evidence": "https://tubulis.com/",
      "before_evidence_kind": "live_capture",
      "kind": "acquired",
      "label": "Acquired",
      "summary": "Its homepage says “Tubulis is now part of Gilead Sciences”.",
      "between": {
        "from": "2026-11-06T21:29:02.815Z",
        "to": "2026-11-06T21:29:02.815Z"
      },
      "evidence": "https://tubulis.com/",
      "evidence_kind": "live_capture",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/acquired"
    }
  ],
  "update": null,
  "same_space": [
    {
      "name": "Solve Therapeutics",
      "record": "https://startuphistory.org/c/solvetx.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "Combotope Therapeutics",
      "record": "https://startuphistory.org/c/combotopetherapeutics.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "Mablink Bioscience",
      "record": "https://startuphistory.org/c/mablink.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "Duality Biologics",
      "record": "https://startuphistory.org/c/dualitybiologics.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "CrossBridge Bio",
      "record": "https://startuphistory.org/c/crossbridgebio.com",
      "basis": "description_similarity",
      "category": null
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Tubulis” company record, https://startuphistory.org/c/tubulis.com"
}